Captrust Financial Advisors Astrazeneca PLC Transaction History

Captrust Financial Advisors

$30.9 Billion
Q2 2024

A detailed history of Captrust Financial Advisors transactions in Astrazeneca PLC stock. As of the latest transaction made, Captrust Financial Advisors holds 145,134 shares of AZN stock, worth $11.4 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

145,134

Previous 126,348 14.87%

Holding current value

$11.4 Million

Previous $8.56 Million 32.23%

% of portfolio

0.04%

Previous 0.03%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$66.81 - $80.83 $1.26 Million - $1.52 Million	18,786 Added 14.87%	145,134 $11.3 Million
Q1 2024 May 15, 2024	BUY	$61.03 - $69.57 $216,290 - $246,556	3,544 Added 2.89%	126,348 $8.56 Million
Q4 2023 Feb 14, 2024	BUY	$61.89 - $69.28 $308,459 - $345,291	4,984 Added 4.23%	122,804 $8.27 Million
Q3 2023 Nov 14, 2023	BUY	$64.85 - $71.7 $320,099 - $353,911	4,936 Added 4.37%	117,820 $7.98 Million
Q2 2023 Aug 14, 2023	SELL	$69.91 - $75.81 $311,518 - $337,809	-4,456 Reduced 3.8%	112,884 $8.08 Million
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $486,444 - $551,534	7,703 Added 7.03%	117,340 $8.14 Million
Q4 2022 Feb 15, 2023	BUY	$54.21 - $70.44 $586,497 - $762,090	10,819 Added 10.95%	109,637 $7.43 Million
Q3 2022 Nov 16, 2022	BUY	$53.02 - $135.75 $1.86 Million - $4.77 Million	35,111 Added 55.11%	98,818 $5.42 Million
Q2 2022 Aug 23, 2022	SELL	$59.26 - $71.14 $176,120 - $211,428	-2,972 Reduced 4.46%	63,707 $4.21 Million
Q2 2022 Aug 16, 2022	BUY	$59.26 - $71.14 $374,878 - $450,031	6,326 Added 10.48%	66,679 $4.41 Million
Q1 2022 May 16, 2022	BUY	$55.72 - $67.12 $387,476 - $466,752	6,954 Added 13.02%	60,353 $4 Million
Q4 2021 Feb 14, 2022	BUY	$54.02 - $63.83 $112,469 - $132,894	2,082 Added 4.06%	53,399 $3.11 Million
Q3 2021 Nov 16, 2021	BUY	$55.56 - $60.79 $1.06 Million - $1.16 Million	19,050 Added 59.04%	51,317 $3.08 Million
Q2 2021 Aug 16, 2021	SELL	$48.42 - $60.18 $53,455 - $66,438	-1,104 Reduced 3.31%	32,267 $1.93 Million
Q1 2021 May 17, 2021	SELL	$47.16 - $54.44 $12,968 - $14,971	-275 Reduced 0.82%	33,371 $1.66 Million
Q4 2020 Feb 16, 2021	SELL	$48.52 - $58.02 $384,229 - $459,460	-7,919 Reduced 19.05%	33,646 $1.68 Million
Q3 2020 Nov 17, 2020	BUY	$53.07 - $61.1 $49,620 - $57,128	935 Added 2.3%	41,565 $2.26 Million
Q2 2020 Aug 14, 2020	BUY	$43.1 - $55.31 $145,462 - $186,671	3,375 Added 9.06%	40,630 $2.17 Million
Q1 2020 May 15, 2020	SELL	$37.79 - $51.33 $24,487 - $33,261	-648 Reduced 1.71%	37,255 $1.63 Million
Q4 2019 Feb 14, 2020	BUY	$42.46 - $50.46 $1.61 Million - $1.91 Million	37,903 New	37,903 $1.91 Million

Others Institutions Holding AZN

# of Institutions

1,332

Shares Held

490M

Call Options Held

4.99M

Put Options Held

3.19M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $243B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Account

Captrust Financial Advisors Astrazeneca PLC Transaction History